AU2002354476A1 - Pyrazolopyridine derivatives and medicinal use thereof - Google Patents
Pyrazolopyridine derivatives and medicinal use thereofInfo
- Publication number
- AU2002354476A1 AU2002354476A1 AU2002354476A AU2002354476A AU2002354476A1 AU 2002354476 A1 AU2002354476 A1 AU 2002354476A1 AU 2002354476 A AU2002354476 A AU 2002354476A AU 2002354476 A AU2002354476 A AU 2002354476A AU 2002354476 A1 AU2002354476 A1 AU 2002354476A1
- Authority
- AU
- Australia
- Prior art keywords
- medicinal use
- pyrazolopyridine derivatives
- pyrazolopyridine
- derivatives
- medicinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001382398 | 2001-12-14 | ||
JP2001-382398 | 2001-12-14 | ||
JP2002225343 | 2002-08-01 | ||
JP2002-225343 | 2002-08-01 | ||
PCT/JP2002/013059 WO2003051876A1 (en) | 2001-12-14 | 2002-12-13 | Pyrazolopyridine derivatives and medicinal use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002354476A1 true AU2002354476A1 (en) | 2003-06-30 |
Family
ID=26625083
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002354476A Abandoned AU2002354476A1 (en) | 2001-12-14 | 2002-12-13 | Pyrazolopyridine derivatives and medicinal use thereof |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPWO2003051876A1 (en) |
AU (1) | AU2002354476A1 (en) |
WO (1) | WO2003051876A1 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8765783B2 (en) | 2002-06-26 | 2014-07-01 | Ono Pharmaceuticals Co., Ltd. | Pharmaceutical composition for treatment of disease due to vascular constriction or vasodilation |
CA2498944C (en) | 2002-09-19 | 2011-05-17 | Yasushi Kohno | Amino alcohol derivatives, salts thereof and immunosuppressive agents |
AU2003289024A1 (en) * | 2002-12-12 | 2004-06-30 | Takeda Pharmaceutical Company Limited | Novel use of edg receptors |
EP2172472B1 (en) | 2003-02-18 | 2012-12-26 | Kyorin Pharmaceutical Co., Ltd. | Aminophosphonic acid derivative, salt thereof and modulator of S1P receptor |
CN102964294A (en) | 2004-09-02 | 2013-03-13 | 遗传技术研究公司 | Pyridyl inhibitors of hedgehog signalling |
WO2007087429A2 (en) * | 2006-01-25 | 2007-08-02 | Synta Pharmaceuticals Corp. | Phenyl and pyridyl compounds for inflammation and immune-related uses |
JP4948913B2 (en) * | 2006-06-16 | 2012-06-06 | 上野製薬株式会社 | Method for producing naphthalenecarboxylic acid amide |
RU2430925C2 (en) | 2006-08-08 | 2011-10-10 | Киорин Фармасьютикал Ко., Лтд. | Aminophosphate derivative and s1p receptor modulator containing said derivative as active ingredient |
US8273748B2 (en) | 2006-08-08 | 2012-09-25 | Kyorin Pharmaceutical Co., Ltd. | Amino alcohol derivative and immunosuppresive agent having same as an active ingredient |
AU2009305565A1 (en) | 2008-10-17 | 2010-04-22 | Exelixis, Inc. | Synergistic combination of sphingosine-1-phosphate receptor antagonists and antimicrotubule agents |
JP2013506003A (en) * | 2009-09-29 | 2013-02-21 | アラーガン インコーポレイテッド | Fused ring pyridine compounds as subtype-selective modulators of sphingosine-1-phosphate-2 (S1P2) receptors |
JPWO2011087051A1 (en) * | 2010-01-14 | 2013-05-20 | 国立大学法人金沢大学 | Atherosclerosis therapeutic agent comprising S1P2 receptor antagonist |
CN104334556B (en) * | 2012-03-26 | 2017-05-17 | 爱若优生物科技有限公司 | Novel sphingosine 1-phosphate receptor antagonists |
WO2015184541A1 (en) | 2014-06-02 | 2015-12-10 | Dalhousie University | Treatment of familial exudative vitreoretinopathy through s1pr2 inhibition |
US10487082B2 (en) | 2015-06-01 | 2019-11-26 | Dalhousie University | S1PR2 antagonists and uses therefor |
CA2987796A1 (en) * | 2015-06-01 | 2016-12-08 | Dalhousie University | S1pr2 antagonists and uses therefor |
US10858358B2 (en) | 2015-06-01 | 2020-12-08 | Dalhousie University | S1PR2 antagonists and uses therefor |
US10464897B2 (en) * | 2015-06-05 | 2019-11-05 | Dana-Farber Cancer Institute, Inc. | Compounds and methods for treating cancer |
BR112019001732A2 (en) * | 2016-07-29 | 2019-05-07 | Flx Bio, Inc. | chemokine receptor modulators and uses thereof |
CN111918652A (en) | 2017-11-06 | 2020-11-10 | 拉普特医疗公司 | Chemokine receptor modulators for the treatment of epstein-barr virus positive cancers |
CN110950807B (en) * | 2018-09-26 | 2023-03-03 | 中国科学院上海药物研究所 | Biaryl compound, preparation method thereof, pharmaceutical composition and application thereof |
WO2023283921A1 (en) * | 2021-07-16 | 2023-01-19 | 北京深蓝泰医药科技有限公司 | Dpd inhibitor, and pharmaceutical composition and use thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020027463A (en) * | 1999-07-12 | 2002-04-13 | 우에노 도시오 | Fibrosis inhibitors containing as the active ingredient sphingosine-1-phosphate receptor agonist or sphingosine-1-phosphate |
GB9929685D0 (en) * | 1999-12-15 | 2000-02-09 | Merck Sharp & Dohme | Therapeutic agents |
-
2002
- 2002-12-13 WO PCT/JP2002/013059 patent/WO2003051876A1/en active Application Filing
- 2002-12-13 AU AU2002354476A patent/AU2002354476A1/en not_active Abandoned
- 2002-12-13 JP JP2003552760A patent/JPWO2003051876A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2003051876A1 (en) | 2003-06-26 |
JPWO2003051876A1 (en) | 2005-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001264313A1 (en) | Pyrazolopyridine compounds and use thereof as drugs | |
AU2001280188A1 (en) | Pyrazolopyridine compound and pharmaceutical use thereof | |
EP1367060A4 (en) | Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof | |
EP1364957A4 (en) | Glycopyranosyloxypyrazole derivatives and medicinal use thereof | |
EP1364958A4 (en) | Glycopyranosyloxypyrazole derivatives and medicinal use thereof | |
AU2002340999A1 (en) | Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use | |
AU2002354476A1 (en) | Pyrazolopyridine derivatives and medicinal use thereof | |
AU2001277741A1 (en) | 2-aminopyridine compounds and use thereof as drugs | |
AU2001277754A1 (en) | Proline derivatives and use thereof as drugs | |
AU1164601A (en) | Therapeutic use and formulation | |
AU2003269018A1 (en) | Acylaminothiazole derivatives, preparation and therapeutic use thereof | |
PL362571A1 (en) | Beta-carboline derivatives and its pharmaceutical use against depression and anxiety | |
AU2002343103A1 (en) | Aminoalkylimidazole derivatives and their use in medicine | |
AU2002308891A1 (en) | Novel heterocyclic derivatives and medicinal use thereof | |
AU2002359618A1 (en) | Medicinal compositions and therapeutic methods | |
AUPQ462299A0 (en) | Pyrazolopyridine compound and pharmaceutical use thereof | |
AUPR916301A0 (en) | Pyrazolopyridine compound and pharmaceutical use thereof | |
AUPR606401A0 (en) | Pyrazolopyridine compound and pharmaceutical use thereof | |
AU2001284084A1 (en) | Polyfluoroalkyltriazole derivatives, preparation and therapeutic use thereof | |
AU2002308105A1 (en) | Benzoaxathiepin derivatives and their use as medicines | |
AUPR548601A0 (en) | Pyrazolopyrazinecompound and pharmaceutical use thereof | |
AU2001228784A1 (en) | Inositol derivatives and their pharmaceutical use | |
AU2002347633A1 (en) | Pyrazolopyridine derivtives and their pharmaceutical use | |
AU2002234871A1 (en) | Glucopyranosyloxybenzylbenzene derivatives and medicinal use thereof | |
AU2002237536A1 (en) | Glycopyranosyloxypyrazole derivatives and medicinal use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |